Blog
874 Articles
Cancer Commons and xCures Hope to Use Real-World Data to Improve Care
Lola Rahib and Patrick van der Valk explain how Cancer Commons and xCures are using real-world data to improve care for future patients.
Using the Lessons of Recovery in my Pancreatic Cancer Treatment
Robert Hessler used the lessons he learned as a recovering alcoholic to help him through the challenges of a Whipple procedure.
My Eight-Year Un-Celebration of Surviving Pancreatic Cancer
William Ramshaw shares his thoughts and advice for those in treatment, on reaching the eight-year pancreatic cancer survivor mark.
I Didn’t Expect to Be Doing This
Sheila Sky Kasselman, a long-term survivor of pancreatic cancer, started a foundation to help others after recovering from Whipple surgery.
Platform Trial Design Aims to Get Information Quickly and Efficiently
Dr. Eugene Koay is leading a platform trial, for a more nimble way to adapt to participants’ response to treatments being tested.
Endurance Athlete Enduring Pancreatic Cancer Treatment
After a stage IV pancreatic cancer diagnosis, Dr. Kevin Moore had cytoreductive surgery to remove the metastases in his abdomen.
Understanding Who Is at High Risk for Pancreatic Cancer
Who is high-risk for pancreatic cancer? Oncologist Dr. Matthew Yurgelun explains high-risk populations and what steps to take if you meet the criteria.
A Clinical Trial Gives Me Hope
When Dennis Rues’s pancreatic cancer recurred, his doctors recommended that he join a clinical trial. Now he’s doing well.
Liquid Biopsies: What You Should Know
Three different liquid biopsy blood tests are under development or now available for pancreatic and other cancers.
Let’s Win Lunch and Learn: Pancreatic Cancer and Diabetes
In a special Lunch and Learn webinar, doctors and diabetes educators discuss the relationship between pancreatic cancer and diabetes.
If You Believe You Can Do This . . .
Barry Hendrickson spent much of his career helping cancer patients with hair loss, but he never expected to be in their shoes.
A Report from ASCO GI 2022
Clinical trials were reported on at ASCO GI 2022, as well as reports on COVID, virtual tumor boards, and racial disparities in treatment.
Family, Friends, Hope, Strength, and Prayer
Susan Wells had chemotherapy but her treatment took a detour into more chemo and a clinical trial before she had a Whipple procedure.
Modifying the Tumor Microenvironment to Make Treatment More Effective
Researchers are testing a new drug that better-allows chemotherapy to penetrate the tumor microenvironment of pancreatic cancer.
New Study Aims to Reduce Recurrence Risk for Select Patients
Dr. Kim A. Reiss is leading a study of the PARP inhibitor olaparib to delay or prevent a recurrence of surgically removed pancreatic cancer.